RadNet Acquires iCAD to Enhance AI-Powered Breast Cancer Screening Solutions Through DeepHealth Integration.

viernes, 18 de julio de 2025, 1:09 am ET1 min de lectura
ICAD--
RDNT--

RadNet has acquired iCAD to enhance its AI-powered breast cancer screening solutions through DeepHealth integration. The acquisition enhances DeepHealth's capabilities in breast cancer detection and diagnosis, expanding its global access to diagnostic solutions. The combined portfolio aims to improve breast cancer detection rates and streamline screening workflows. The acquisition is expected to impact over 10 million mammograms annually.

RadNet Acquires iCAD to Enhance AI-Powered Breast Cancer Screening Solutions Through DeepHealth Integration.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios